⇚ Regimen CABOMETYX® - for Renal Cancer Medical Name CABOMETYX® (Cabozantinib) - for Advanced Renal Cancer Cycles Given 6 Delivery Phases N/A Special Instructions Monitor closely for nausea, vomiting, diarrhea and palmar-plantar erythrodysesthesia syndrome. Treatment continued until disease progression or unacceptable toxicity References Choueiri TK, et al. NEJM 2015 - VIEW External References http://www.nejm.org/doi/full/10.1056/NEJMoa1510016#t=abstract - VIEW Drug Mode Given Standard Dose Days to Be Given Frequency Solution Volume Duration CABOMETYX® (Cabozantinib) PO 60 mg Daily until Disease Progression N/A N/A N/A N/A